Explore Watchlists Pricing

CHUGAI PHARMACEUTICAL CO., LTD. (4519) Balance sheet

Market cap

¥14.42T

P/E ratio

35.2x

Chugai Pharmaceutical develops and sells prescription medicines in Japan and internationally, with research operations spanning the US, Europe, and Asia.

Summary Financials Dividends History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12	2025/12
Cash and cash equivalents	-	91,439	76,333	73,580	105,576	106,404	203,941	212,333	267,753	222,169	458,674	540,202	426,602
Marketable securities, current	-	98,996	120,996	95,998	96,000	102,001	127,991	164,988	199,989	254,986	250,115	455,621	550,253
Accounts receivable, net	-	-	-	-	-	179,556	181,641	253,342	355,081	512,538	318,892	334,256	442,876
Inventories	-	69,634	68,058	75,745	82,160	75,748	168,122	183,893	208,838	292,206	273,480	240,067	276,848
Total current assets	-	496,139	531,973	546,360	587,328	594,731	699,680	834,906	1,063,661	1,336,537	1,366,426	1,606,043	1,740,758
Property, plant and equipment, net	-	47,838	44,205	47,379	46,649	87,005	255,559	289,218	338,841	375,340	409,939	433,129	456,578
Marketable securities, non-current	-	9,856	12,839	8,725	10,305	8,607	2,986	3,050	11,534	10,310	12,950	13,392	16,282
Total non-current assets	-	138,205	138,016	143,508	145,967	202,468	359,235	400,592	475,033	533,221	566,121	602,330	727,837
Total assets	-	634,344	669,989	689,868	733,295	919,548	1,058,915	1,235,498	1,538,694	1,869,758	1,932,547	2,208,373	2,468,595
Accounts payable	-	-	-	-	-	71,706	77,635	100,396	152,266	209,835	112,468	65,353	127,247
Long-term debt, current	-	-	-	-	-	133	-	-	-	-	-	-	-
Total current liabilities	-	113,488	119,998	115,348	117,621	128,235	179,268	236,070	327,422	423,730	288,217	290,357	411,077
Total non-current liabilities	-	6,149	2,940	3,764	5,737	7,434	25,662	19,425	23,255	21,641	18,750	16,516	31,785
Total liabilities	-	119,637	122,938	119,111	123,358	163,019	204,930	255,495	350,677	445,372	306,967	306,873	442,862
Retained earnings	-	376,793	407,515	426,849	466,169	517,695	616,906	733,234	929,305	1,158,504	1,351,597	1,604,863	1,706,669
Stockholders' equity	490,158	514,707	547,051	570,756	609,937	661,530	853,985	980,003	1,188,017	1,424,387	1,625,580	1,901,499	2,025,732
Working capital	-	-	-	-	-